CTI BioPharma
CTIC
#5625
Rank
$1.19 B
Marketcap
$9.09
Share price
0.00%
Change (1 day)
30.79%
Change (1 year)

CTI BioPharma (CTIC) - Total liabilities

Total liabilities on the balance sheet as of March 2023 : $0.13 Billion USD

According to CTI BioPharma 's latest financial reports the company's total liabilities are $0.13 Billion USD. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

CTI BioPharma - Total liabilities on balance sheet (from 2001 to 2023)

Total liabilities by year

Year Total liabilities Change
2022-12-31$0.14 B108.98%
2021-12-31$68.66 M277.04%
2020-12-31$18.21 M-35.76%
2019-12-31$28.35 M-23.16%
2018-12-31$36.89 M-4.91%
2017-12-31$38.79 M-30.83%
2016-12-31$56.08 M-42.13%
2015-12-31$96.91 M80.12%
2014-12-31$53.8 M5.58%
2013-12-31$50.96 M25.01%
2012-12-31$40.76 M19.1%
2011-12-31$34.23 M-41.72%
2010-12-31$58.73 M-33.53%
2009-12-31$88.36 M-52.97%
2008-12-31$0.18 B3.58%
2007-12-31$0.18 B-10.83%
2006-12-31$0.20 B-22.52%
2005-12-31$0.26 B2.67%
2004-12-31$0.25 B11.84%
2003-12-31$0.22 B59.55%
2002-12-31$0.14 B-26.21%
2001-12-31$0.19 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Amgen
AMGN
$80.52 B 58,410.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$78.28 B 56,788.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
$1.67 B 1,120.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
$13.85 B 9,966.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$91.08 B 66,086.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
$32.60 B 23,590.04%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Novartis
NVS
$62.53 B 45,342.13%๐Ÿ‡จ๐Ÿ‡ญ Switzerland